BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261103T170000
DTEND;TZID=America/New_York:20261103T180000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:FLASCO Legislative Advocacy Training
DESCRIPTION:Join the Florida Society of Clinical Oncology (FLASCO) for a virtual educational webinar designed to equip oncology professionals with the knowledge and tools needed to become effective advocates for patients\, providers\, and the broader cancer care community. Presented by the FLASCO Legislative Committee in partnership with Pfizer Oncology\, this 45-minute program will explore critical federal and state legislative issues shaping the future of oncology care\, including Most Favored Nation (MFN) drug pricing policies\, Medicare Advantage step therapy requirements\, and opportunities to expand clinical trial access throughout Florida.Featuring insights from Michelle Flowers\, Founder of Oncology Managers of Florida\; Patti Jewell-Fine of Pfizer\; and Omar Rashid\, MD\, JD\, FACS\, FSSO\, DABS\, of the FLASCO Legislative Committee\, the session will examine policy challenges\, barriers to timely treatment\, and opportunities for meaningful legislative engagement. Attendees will gain practical perspectives on navigating the evolving healthcare policy landscape\, supporting patient access to care\, and strengthening Florida's role in clinical research. The program will conclude with an interactive Q&A and key advocacy takeaways.Event DetailsDate: Tuesday\, November 3\, 2026Time: 5:00   5:45 PM ETLocation: Virtual Educational WebinarPresented by: FLASCO Legislative CommitteeIn Partnership with: Pfizer OncologyFeatured Sessions & SpeakersMost Favored Nation (MFN) Drug Pricing: Federal Policy & State Implications\nMichelle Flowers\, Founder of Oncology Managers of FloridaMedicare Advantage Step Therapy: Challenges & Advocacy Priorities\nPatti Jewell-Fine\, PfizerExpanding Clinical Trial Opportunities in Florida\nOmar Rashid\, MD\, JD\, FACS\, FSSO\, DABS\, FLASCO Legislative CommitteeThe webinar will conclude with audience Q&A and closing remarks focused on actionable advocacy priorities for Florida's oncology community\, presented in partnership with Pfizer Oncology.
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE html><html><head><title></title></head><body aria-disabled="false"><p><meta charset="utf-8" /></p><p><meta charset="utf-8" /></p><p><meta charset="utf-8" /></p><p data-pm-slice="1 1 []">Join the Florida Society of Clinical Oncology (FLASCO) for a virtual educational webinar designed to equip oncology professionals with the knowledge and tools needed to become effective advocates for patients\, providers\, and the broader cancer care community. Presented by the FLASCO Legislative Committee in partnership with Pfizer Oncology\, this 45-minute program will explore critical federal and state legislative issues shaping the future of oncology care\, including Most Favored Nation (MFN) drug pricing policies\, Medicare Advantage step therapy requirements\, and opportunities to expand clinical trial access throughout Florida.</p><p>Featuring insights from Michelle Flowers\, Founder of Oncology Managers of Florida\; Patti Jewell-Fine of Pfizer\; and Omar Rashid\, MD\, JD\, FACS\, FSSO\, DABS\, of the FLASCO Legislative Committee\, the session will examine policy challenges\, barriers to timely treatment\, and opportunities for meaningful legislative engagement. Attendees will gain practical perspectives on navigating the evolving healthcare policy landscape\, supporting patient access to care\, and strengthening Florida&#39\;s role in clinical research. The program will conclude with an interactive Q&amp\;A and key advocacy takeaways.</p><p><strong fr-original-style="" style="font-weight: 700\;">Event Details</strong></p><ul fr-original-style="" style="list-style-position: inside\;"><li><strong fr-original-style="" style="font-weight: 700\;">Date:</strong> Tuesday\, November 3\, 2026</li><li><strong fr-original-style="" style="font-weight: 700\;">Time:</strong> 5:00 &ndash\; 5:45 PM ET</li><li><strong fr-original-style="" style="font-weight: 700\;">Location:</strong> Virtual Educational Webinar</li><li><strong fr-original-style="" style="font-weight: 700\;">Presented by:</strong> FLASCO Legislative Committee</li><li><strong fr-original-style="" style="font-weight: 700\;">In Partnership with:</strong> Pfizer Oncology</li></ul><p><strong fr-original-style="" style="font-weight: 700\;">Featured Sessions &amp\; Speakers</strong></p><p><strong fr-original-style="" style="font-weight: 700\;">Most Favored Nation (MFN) Drug Pricing: Federal Policy &amp\; State Implications</strong><br />Michelle Flowers\, Founder of Oncology Managers of Florida</p><p><strong fr-original-style="" style="font-weight: 700\;">Medicare Advantage Step Therapy: Challenges &amp\; Advocacy Priorities</strong><br />Patti Jewell-Fine\, Pfizer</p><p><strong fr-original-style="" style="font-weight: 700\;">Expanding Clinical Trial Opportunities in Florida</strong><br />Omar Rashid\, MD\, JD\, FACS\, FSSO\, DABS\, FLASCO Legislative Committee</p><p>The webinar will conclude with audience Q&amp\;A and closing remarks focused on actionable advocacy priorities for Florida&#39\;s oncology community\, presented in partnership with Pfizer Oncology.</p><p><br /></p></body></html>
LOCATION:FL
UID:e.603.1665373
SEQUENCE:3
DTSTAMP:20261026T125100Z
URL:https://members.flasco.org/calendarofevents/Details/flasco-legislative-advocacy-training-1963197?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR